Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288(19): 2411-20.
Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J 2007; 154(2): 221-31.
Hulot JS, Bura A, Villard E, Azizi M, Remones V, Goyenvalle C, et al. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood 2006; 108(7): 2244-7.
1School of Paramedicine, Tehran Medical Branch of Islamic Azad University, Tehran, Iran 2School of Medicine, Alborz University of Medical Sciences, Karaj, Iran 3Peyvand Clinical & Specialty Laboratory, Tehran, Iran
Abstract Background and Objectives
Clopidogrel is one of the most commonly prescribed drugs to prevent ischemic events following coronary syndromes or stent placement. The objective of this study was to evaluate the prevalence of the cytochrome P450 (CYP450) 2C19 enzyme (CYP2C19) genotypes in the Iranian population.
Materials and Methods
CYP2C19 (*1/*2/*3) variants were analyzed using Polymerase Chain Reaction-Restriction Length Polymorphism (PCR–RFLP) assays in a representative sample of 154 Iranian patients with ischemic heart disease in Peyvand Laboratory.
Results
In this study, out of 154 Iranian patients the frequency rates of CYP2C19 *2 were 36 (23.4%) in heterozygous and 6 (3.9%) in homozygous forms; 112 (72.7%) patients had the normal genotype.
Conclusions
FDA recommendations are more useful to be practiced in our country than other countries. Physicians should identify patients and advise them to consider other antiplatelet medications or alternative dosing strategies in poor metabolizers.
Correspondence: Poopak B., PhD of Hematology. Assistant Professor of School of Paramedicine, Tehran Medical Branch of Islamic Azad University.
P.O.Box: 19395-1495, Tehran, Iran. Tel: (+9821) 22257438; Fax : (+9821) 22257438
E-mail: bpoopak@yahoo.com
Poopak B, Taghdisi S, Heidari M, Fallah P, Khosravipour G, Bolouri S et al . Evaluation of common polymorphisms of CYP2C19 in Clopidogrel-treated patients. Sci J Iran Blood Transfus Organ 2014; 11 (3) :190-196 URL: http://bloodjournal.ir/article-1-782-en.html